Tempus AI (TEM) EBITDA Margin (2023 - 2026)
Tempus AI's (TEM) quarterly EBITDA Margin came in at 19.85% in Q2 2026, down 21.0% year-over-year from 25.12% in Q2 2025, and up 18.44% quarter-over-quarter from 24.33% in Q1 2026.
Powered by 
Analysis
Tempus AI (TEM) EBITDA Margin (2023 - 2026) Analysis & Trends
Tempus AI (TEM) has reported EBITDA Margin for 4 consecutive years, with 19.85% the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBITDA Margin fell 21.0% year-over-year to 19.85% in Q2 2026; TTM through Jun 2026 was 19.76%, a 490.0% increase from a year earlier, with the FY2025 full-year figure at 19.88%, up 7978.0% from the prior year.
- EBITDA Margin was 19.85% for Q2 2026 at Tempus AI, up from 24.33% in the prior quarter.
- Over five years, EBITDA Margin peaked at 16.72% in Q4 2025 and troughed at 321.44% in Q2 2024.
- A 4-year average of 49.3% and a median of 26.86% in 2025 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin slumped 28735 bps in 2024 and surged 30181 bps in 2025, its largest moves.
- Over 4 years, EBITDA Margin stood at 35.4% in 2023, then advanced by 29 bps to 25.26% in 2024, then soared by 34 bps to 16.72% in 2025, then retreated by 19 bps to 19.85% in 2026.
- The last three EBITDA Margin figures came in at 19.85% (Q2 2026), 24.33% (Q1 2026), and 16.72% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 47.13 Bn | 46.03 Bn | 486.15 Mn | -10.07% |
| 2 | Labcorp Holdings | 26.44 Bn | 26.32 Bn | 1.11 Bn | 12.10% |
| 3 | Quest Diagnostics | 26.16 Bn | 25.84 Bn | 1.03 Bn | 15.08% |
| 4 | Guardant Health | 21.57 Bn | 20.51 Bn | 219.03 Mn | -38.55% |
| 5 | Tempus AI | 11.32 Bn | 10.51 Bn | 274.25 Mn | -19.85% |
| 6 | Caris Life Sciences | 7.08 Bn | 6.29 Bn | 182.38 Mn | 10.21% |
| 7 | Sotera Health | 5.39 Bn | 5.04 Bn | 177.96 Mn | 34.17% |
| 8 | BillionToOne | 4.65 Bn | 4.11 Bn | 77.11 Mn | 5.03% |
| 9 | iRhythm Holdings | 4.05 Bn | 3.46 Bn | 163.21 Mn | -1.13% |
| 10 | Adaptive Biotechnologies | 3.86 Bn | 3.53 Bn | 51.39 Mn | -22.04% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -19.85% |
| Mar 31, 2026 | -24.33% |
| Dec 31, 2025 | -16.72% |
| Sep 30, 2025 | -18.25% |
| Jun 30, 2025 | -19.63% |
| Mar 31, 2025 | -26.86% |
| Dec 31, 2024 | -25.26% |
| Sep 30, 2024 | -29.63% |
| Jun 30, 2024 | -321.44% |
| Mar 31, 2024 | -36.53% |
| Dec 31, 2023 | -35.40% |
| Sep 30, 2023 | -32.92% |
| Jun 30, 2023 | -34.09% |